USPTO serial 79416924
PARTNERS FOR THE PLANET
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 28, 2025
- Examiner
- NOLASCO-ARIAS, KENNETH E
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PARTNERS FOR THE PLANET?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
FUJIFILM Diosynth Biotechnologies UK Limited
GB
Other trademarks owned by FUJIFILM Diosynth Biotechnologies UK Limited
FUJIFILM Diosynth Biotechnologies UK Limited
GB
Other trademarks owned by FUJIFILM Diosynth Biotechnologies UK Limited
FUJIFILM Diosynth Biotechnologies UK Limited
GB
Other trademarks owned by FUJIFILM Diosynth Biotechnologies UK Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Allisen Pawlenty
Allisen Pawlenty Coates IP3057 Nutley St. #801Fairfax, VA 22031United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 037 | Construction services, namely, the building and installation of pharmaceutical and biopharmaceutical manufacturing facilities; building construction services; construction of pharmaceutical facilities; construction management services, namely, onsite management relating to the construction of pharmaceutical manufacturing facilities; building and construction of factories; custom construction of factories and pharmaceutical manufacturing facilities; information, advice and consultancy in relation to all the aforesaid | ACTIVE | — |
| 040 | Custom processing and manufacturing of biopharmaceuticals; custom processing and manufacturing of pharmaceuticals; custom manufacture of pharmaceuticals; manufacture, processing and production of recombinant proteins for use in the biotechnology industries to the order and specification of others; cell culture manufacturing services for others; custom manufacture of biologics; information, advice and consultancy in relation to all the aforesaid | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis and testing in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; research and development in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; scientific analysis in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; industrial and technical research, development and analysis services; scientific, industrial process development in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; development of processes for the use and manufacture of biotechnology products; technical project studies in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; industrial process development in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; development of processes for the use in the manufacture of biotechnology products; biotechnology product testing services; research and consultancy in the field of biotechnology; research and development in the pharmaceutical and biotechnology industry; scientific, technological and pharmaceutical process development and design in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; biopharmaceutical product development; computer software development, programming and implementation for others; design and development of computer software; design and development of manufacturing processes in the field of biopharmaceuticals; design of manufacturing methods; design of industrial buildings; design of manufacturing plants; engineering services in the fields of biotechnology, biologics, biopharmaceuticals and pharmaceuticals; medical and biological research laboratory services; preparation of biological samples for analysis in research laboratories; development of processes for use in the manufacture of products in the biotechnology industry; design services relating to manufacturing plants for the biotechnology industry; information, advice and consultancy in relation to all the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by FUJIFILM Diosynth Biotechnologies UK Limited
- Other trademarks owned by FUJIFILM Diosynth Biotechnologies UK Limited
- Other trademarks owned by FUJIFILM Diosynth Biotechnologies UK Limited
- Other trademarks in Class 037
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named PARTNERS FOR THE PLANET
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 5, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 21, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 21, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 28, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 11, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 11, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 7, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 24, 2026 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jan 28, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 29, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 28, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 28, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 8, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 8, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 8, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 8, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 8, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 18, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 18, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 18, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 23, 2025 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| May 10, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 15, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 14, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 11, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 11, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 11, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 11, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 7, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 6, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 17, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 17, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 13, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |